4//SEC Filing
Mohindru Mani 4
Accession 0001209191-19-042480
CIK 0001346830other
Filed
Jul 16, 8:00 PM ET
Accepted
Jul 17, 5:46 PM ET
Size
9.7 KB
Accession
0001209191-19-042480
Insider Transaction Report
Form 4
Mohindru Mani
CFO & Chief Strategy Officer
Transactions
- Sale
Common Stock
2019-07-15$25.00/sh−37,431$935,775→ 13,863 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2019-07-15−37,431→ 299,444 totalExercise: $14.06Exp: 2027-08-15→ Common Stock (37,431 underlying) - Exercise/Conversion
Common Stock
2019-07-15$14.06/sh+37,431$526,280→ 51,294 total
Footnotes (3)
- [F1]This exercise and corresponding sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 7, 2018.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 - $25.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- [F3]One-fourth (1/4th) of the 385,000 shares subject to this option vested and became exercisable on August 15, 2018; the balance of the shares shall vest and become exercisable in a series of 36 successive equal monthly installments measured from August 15, 2018, subject to the reporting person's continuous service with the issuer as of each such date.
Documents
Issuer
Cara Therapeutics, Inc.
CIK 0001346830
Entity typeother
Related Parties
1- filerCIK 0001664708
Filing Metadata
- Form type
- 4
- Filed
- Jul 16, 8:00 PM ET
- Accepted
- Jul 17, 5:46 PM ET
- Size
- 9.7 KB